Use of muscle cells to mediate gene transfer to the bone defect

Tissue Engineering

Volumn 5, Issue 2, 1999, Pages 119-125

  Day, Charles S ^a   Bosch, Patrick ^a   Kasemkijwattana, Channarong ^a,b   Menetrey, Jacques ^a,b   Moreland, Morey S ^a   Fu, Freddie H ^a,b   Ziran, Bruce ^b   Huard, Johnny ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; DESMIN; RECOMBINANT PROTEIN; VIRUS LARGE T ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; BONE DEFECT; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HISTOCHEMISTRY; IMMUNOFLUORESCENCE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033006019     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1999.5.119     Document Type: Article

References (31)

1. Aikawa, T., Shirasuna, K., Iwamoto, M., et al. Establishment of bone morphogenetic protein-2 responsive chondrogenic cell line. J. Bone Miner. Res. 11, 544, 1996.
2. Bostrom, M.P.G., Lane, J.M., Tomin, E., et al. The use of rhBMP-2 in the rabbit ulnar non-union model: a radiograph, biochemical and histological dose response study. Orthop. Res. Soc. 20, 229, 1995.
3. Cook, S.D., Baffes, G.C., Wolfe, M., et al. The effects of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Joint Surg. Am. 76A, 827, 1994.
4. Dai, Y., Roman, M., Naviaux, R., et al. Gene therapy via primary myoblasts, long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. U.S.A. 89, 10892, 1992.
5. Day, C.S., Kasemkijwattana, C., Menetrey, J., et al. Myoblast-mediated gene transfer to the joint. J. Orthop. Res. 15, 894, 1997.
6. Dhawan, J., Pan, L.C., Pavlath, G.K., et al. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509, 1992.
7. Enneking, W.F., Eady, J.L., and Burchardt, H. Autologous cortical bone grafts in the reconstruction of segmental skeletal defects. J. Bone Joint Surg. Am. 62A, 1039, 1980.
8. Evans, C.H., and Robbins, P.D. Current concepts review: possible orthopaedic applications of gene therapy. J. Bone Joint Surg. Am. 77A, 1103, 1995.
9. Floyd, Jr., S.S., Clemens, P.R., Ontell, M.R., et al. Ex vivo gene transfer using adenovirus mediated full-length dystrophin delivery to mature dystrophic muscles. Gene Ther. 5, 19, 1998.
10. Fowler, B.L., Dall, B.E., and Rowe, D.E. Complications associated with harvesting autogenous iliac bone graft. Am. J. Orthop. 24, 895, 1995.
11. Friedenstein, A.J., Gorskaja, J.F., and Kulagina, N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4, 267, 1976.
12. Goldstrohm, G.L., Mears, D.C., and Swartz, W.M. The results of 39 fractures complicated by major segmental bone loss and/or leg length discrepancy. J. Trauma 24, 50, 1984.
13. Huard, J., Verreault, S., Roy, R., et al. High efficiency of muscle regeneration following human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93, 586, 1994.
14. Jiao, S., Williams, P., Safda, N., et al. Co-transplantation of plasmid-transfected myoblasts and myotubes into rat brains enables high levels of gene expression long term. Cell Transplant. 2, 185, 1993.
15. Johnson, E.E., Urist, M.R., and Finerman, G.A. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. Clin. Orthop. 230, 257, 1988.
16. Joyner, C.J., Bennett, A., and Trissitt, J.T. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone 21, 1, 1997.
17. Katagiri, T., Yamaguchi, A., Komaki, M., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755, 1994.
18. Khouri, R.K., Brown, D.M., Koudsi, B., et al. Repair of calvarial defect with flap tissue: role of bone morphogenetic proteins and competent responding tissues. Plast. Reconstr. Surg. 98, 103, 1996.
19. Lau, H.T., Yu, M., Fontana, A., et al. Prevention of islet allograft rejection with engineered myoblasts expressing fasL in mice. Science 273, 109, 1996.
20. Lieberman, J.R., Le, L.Q., Tomin, E., et al. Genetic transfer of recombinant BMP-2 into a stromal cell line induces bone formation in vivo. Orthop. Res. Soc. 21, 198, 1996.
21. Morgan, J.E., Beauchamp, J.R., Pagel, C.N., et al. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162, 486, 1994.
22. Mundy, G. Regulation of bone formation by morphogenetic proteins and other growth factors. Clin. Orthop 323, 24, 1996.
23. Prokuski, L.J., and Marsh, J.L. Segmental bone deficiency after acute trauma. The role of bone transport. Orthop. Trauma 25, 753, 1994.
24. Rando, T.A., and Blau, H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125, 1275, 1994.
25. Sandhu, H., Kanim, L.E., Kabo, J.M., et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21, 2115, 1996.
26. Simonson, G.D., Groskreutz, D.J., Gorman, C.M., et al. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum. Gene Ther. 7, 71, 1996.
27. Summers, B.N., and Eisenstein, S.M. Donor site pain from the ilium. A complication of lumbar spine fusion. J. Bone Joint Surg. Am. 71A, 677, 1989.
28. Urist, M.R. Bone formation by autoinduction. Science 150, 893, 1965.
29. Vandenburgh, H., Del Tatto, M., Shansky, J., et al. Tissue-engineered skeletal muscle organoids for reversible gene therapy. Hum. Gene Ther. 7, 2195, 1996.
30. Wozney, J.M., Rosen, V., Celeste, A.J., et al. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528, 1988.
31. Yasko, A.W., Lane, J.M., Fellinger, E.J., et al. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J. Bone Joint Surg. Am. 74A, 659, 1992.